Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arleigh R McCurdy

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Therapeutic Advances in Hematology|June 5, 2013
Pomalidomide and its clinical potential for relapsed or refractory multiple myeloma: an update for the hematologistArleigh R McCurdy, Martha Q Lacy
Blood|August 27, 2013
PomalidomideMartha Q Lacy, Arleigh R McCurdy
The Canadian Journal of Cardiology|April 12, 2017
Cardiac Amyloidosis Phenotype Associated With a Glu89Lys Transthyretin MutationPierre R Bourque, Arleigh R McCurdy, Lisa M Mielniczuk, et al.
Blood|July 19, 2013
Implications of continued response after autologous stem cell transplantation for multiple myelomaWilson I Gonsalves, Morie A Gertz, Angela Dispenzieri, et al.
Leukemia & Lymphoma|November 1, 2018
Health related quality of life for multiple myeloma patients according to treatment strategy after autologous stem cell transplant: a cross-sectional study using EORTC, EQ-5D and MY-20 scalesJason Tay, Ravi Vij, Maxim Norkin, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Therapeutic Advances in Hematology|June 5, 2013
Pomalidomide and its clinical potential for relapsed or refractory multiple myeloma: an update for the hematologistArleigh R McCurdy, Martha Q Lacy
Blood|August 27, 2013
PomalidomideMartha Q Lacy, Arleigh R McCurdy
The Canadian Journal of Cardiology|April 12, 2017
Cardiac Amyloidosis Phenotype Associated With a Glu89Lys Transthyretin MutationPierre R Bourque, Arleigh R McCurdy, Lisa M Mielniczuk, et al.
Blood|July 19, 2013
Implications of continued response after autologous stem cell transplantation for multiple myelomaWilson I Gonsalves, Morie A Gertz, Angela Dispenzieri, et al.
Leukemia & Lymphoma|November 1, 2018
Health related quality of life for multiple myeloma patients according to treatment strategy after autologous stem cell transplant: a cross-sectional study using EORTC, EQ-5D and MY-20 scalesJason Tay, Ravi Vij, Maxim Norkin, et al.
Pageof 1